Intraperitoneal injection of in vitro expanded Vγ9Vδ2 T cells together with zoledronate for the treatment of malignant ascites due to gastric cancer

Cancer medicine

Volumn 3, Issue 2, 2014, Pages 362-375

  Wada, Ikuo ^a   Matsushita, Hirokazu ^a   Noji, Shuichi ^a   Mori, Kazuhiko ^a   Yamashita, Hiroharu ^a   Nomura, Sachiyo ^a   Shimizu, Nobuyuki ^a   Seto, Yasuyuki ^a   Kakimi, Kazuhiro ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Gastric cancer; malignant ascites; peritoneal dissemination; V 9V 2 T cell; zoledronate

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; IMIDAZOLE DERIVATIVE; LYMPHOCYTE ANTIGEN RECEPTOR; T-CELL RECEPTOR VDELTA2, HUMAN; T-CELL RECEPTOR VGAMMA9, HUMAN; ZOLEDRONIC ACID;

ADOPTIVE IMMUNOTHERAPY; ADULT; AGED; ASCITES; CLINICAL TRIAL; FEMALE; HUMAN; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; PATHOLOGY; PILOT STUDY; PROCEDURES; STOMACH NEOPLASMS; T LYMPHOCYTE;

ADULT; AGED; ASCITES; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; HUMANS; IMIDAZOLES; IMMUNOTHERAPY, ADOPTIVE; INJECTIONS, INTRAPERITONEAL; MALE; MIDDLE AGED; PILOT PROJECTS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; STOMACH NEOPLASMS; T-LYMPHOCYTES;

EID: 84910138190     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.196     Document Type: Article

References (0)